Svb Wealth LLC Astrazeneca PLC Transaction History

Svb Wealth LLC

$1.85 Billion
Q2 2025

A detailed history of Svb Wealth LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Svb Wealth LLC holds 7,319 shares of AZN stock, worth $609,087. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,319

Previous 11,439 36.02%

Holding current value

$609,087

Previous $840,000 39.17%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$64.87 - $75.0 $267,264 - $309,000	-4,120 Reduced 36.02%	7,319 $511,000
Q1 2025 May 14, 2025	SELL	$65.37 - $77.96 $34,776 - $41,474	-532 Reduced 4.44%	11,439 $840,000
Q4 2024 Feb 05, 2025	BUY	$63.2 - $79.58 $756,567 - $952,652	11,971 New	11,971 $784,000
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $15,232 - $18,429	228 Added 1.73%	13,444 $1.05 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $476,095 - $542,715	-7,801 Reduced 37.12%	13,216 $895,000
Q4 2023 Jan 30, 2024	BUY	$61.89 - $69.28 $53,720 - $60,135	868 Added 4.31%	21,017 $1.42 Million
Q3 2023 Oct 23, 2023	SELL	$64.85 - $71.7 $86,380 - $95,504	-1,332 Reduced 6.2%	20,149 $1.36 Million
Q2 2023 Jul 24, 2023	SELL	$69.91 - $75.81 $171,559 - $186,037	-2,454 Reduced 10.25%	21,481 $1.54 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $63,844 - $72,387	-1,011 Reduced 4.05%	23,935 $1.66 Million
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $33,339 - $43,320	615 Added 2.53%	24,946 $1.69 Million
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $226,978 - $581,145	4,281 Added 21.35%	24,331 $1.33 Million
Q2 2022 Aug 16, 2022	BUY	$59.26 - $71.14 $125,394 - $150,532	2,116 Added 11.8%	20,050 $1.33 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $792,839 - $955,050	-14,229 Reduced 44.24%	17,934 $1.19 Million
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $1.4 Million - $1.65 Million	25,873 Added 411.34%	32,163 $1.87 Million
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $5,722 - $6,261	103 Added 1.66%	6,290 $378,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $433,020 - $538,189	-8,943 Reduced 59.11%	6,187 $370,000
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $260,511 - $300,726	5,524 Added 57.51%	15,130 $752,000
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $24,793 - $29,648	511 Added 5.62%	9,606 $480,000
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $67,292 - $77,474	1,268 Added 16.2%	9,095 $498,000
Q2 2020 Aug 05, 2020	BUY	$43.1 - $55.31 $97,147 - $124,668	2,254 Added 40.45%	7,827 $414,000
Q1 2020 May 11, 2020	BUY	$37.79 - $51.33 $35,824 - $48,660	948 Added 20.5%	5,573 $249,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $196,377 - $233,377	4,625 New	4,625 $231,000

Others Institutions Holding AZN

# of Institutions

1,433

Shares Held

498M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $258B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account